We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$2.7B
AUM Growth
-$139M
Cap. Flow
+$52.8M
Cap. Flow %
1.96%
Top 10 Hldgs %
36.19%
Holding
156
New
11
Increased
63
Reduced
61
Closed
10

Top Buys

1
AZN icon
AstraZeneca
AZN
+$91.1M
2
NVDA icon
NVIDIA
NVDA
+$21.1M
3
APH icon
Amphenol
APH
+$18.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$18.6M
5
CDNS icon
Cadence Design Systems
CDNS
+$11.8M

Top Sells

1
SNPS icon
Synopsys
SNPS
+$23.1M
2
AVGO icon
Broadcom
AVGO
+$13.3M
3
CB icon
Chubb
CB
+$13.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.1M
5
NFLX icon
Netflix
NFLX
+$12.2M

Sector Composition

1 Technology 23.6%
2 Healthcare 16.33%
3 Consumer Discretionary 15.05%
4 Communication Services 12.4%
5 Industrials 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
126
Freeport-McMoran
FCX
$83.9B
$3.13M 0.12%
53,228
-101,274
-66% -$6.12M
MRSH
127
Marsh
MRSH
$87.8B
$3.03M 0.11%
17,485
-4,588
-21% -$825K
INTC icon
128
Intel
INTC
$478B
$2.88M 0.11%
65,220
-76,272
-54% -$3.5M
SPOT icon
129
Spotify
SPOT
$98.3B
$2.87M 0.11%
5,926
-7,592
-56% -$3.81M
LOAR icon
130
Loar Holdings
LOAR
$6.55B
$2.75M 0.1%
48,044
+8,123
+20% +$548K
ICLR icon
131
Icon
ICLR
$13.1B
$2.73M 0.1%
24,663
-4,583
-16% -$626K
CRSP icon
132
CRISPR Therapeutics
CRSP
$4.71B
$2.67M 0.1%
56,066
+547
+1% +$28.9K
LYB icon
133
LyondellBasell Industries
LYB
$19.1B
$2.57M 0.1%
+31,915
New +$1.89M
DBD icon
134
Diebold Nixdorf
DBD
$2.97B
$2.5M 0.09%
33,171
– –
APP icon
135
Applovin
APP
$143B
$2.31M 0.09%
+5,810
New +$2.81M
SOBO
136
South Bow Corp
SOBO
$7.89B
$2.24M 0.08%
67,471
+916
+1% +$27.8K
ZBH icon
137
Zimmer Biomet
ZBH
$17.6B
$2.24M 0.08%
24,782
– –
GGB icon
138
Gerdau
GGB
$9.27B
$1.91M 0.07%
527,933
– –
BP icon
139
BP
BP
$108B
$1.49M 0.06%
+31,800
New +$1.25M
TEAM icon
140
Atlassian
TEAM
$23.7B
$1.21M 0.04%
17,770
-227
-1% -$22.4K
WYNN icon
141
Wynn Resorts
WYNN
$10B
$1.1M 0.04%
10,825
+954
+10% +$104K
ACN icon
142
Accenture
ACN
$87.9B
$1.09M 0.04%
5,500
-8,859
-62% -$2.06M
CR icon
143
Crane Co
CR
$12.6B
$1.09M 0.04%
+6,361
New +$1.22M
STZ icon
144
Constellation Brands
STZ
$22.7B
$1.07M 0.04%
7,137
+458
+7% +$70.8K
MSTR icon
145
Strategy Inc
MSTR
$34.4B
$870K 0.03%
6,969
+1,754
+34% +$251K
IP icon
146
International Paper
IP
$19.9B
$564K 0.02%
15,807
-19,478
-55% -$809K
CNI icon
147
Canadian National Railway
CNI
$78.3B
– –
-61,579
Closed -$6.09M
DUOL icon
148
Duolingo
DUOL
$6.24B
– –
-15,386
Closed -$2.7M
EL icon
149
Estee Lauder
EL
$29.7B
– –
-62,350
Closed -$6.53M
IBM icon
150
IBM
IBM
$200B
– –
-25,660
Closed -$7.6M
3 4 5
6
7

Similar funds

HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $2.7B AUM 23.82% 1-Year Est. Return
TPSF
Texas Permanent School Fund Austin, Texas $2.7B AUM 6.73% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Capital International's Q1 2026 Portfolio in Review

As of Q1 2026, Capital International held 156 positions worth $2.7B, down 4.9% from $2.84B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Capital International's Q1 2026 filing shows 11 new, 63 increased, 61 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 472,311 shares worth $92.3M. The largest sale was Synopsys, an estimated $23.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital International's largest Q1 2026 buy was AstraZeneca: 472,311 shares worth $92.3M.
  • Capital International added most to NVIDIA in Q1 2026, an estimated $21.1M increase.
  • Capital International's biggest Q1 2026 reduction was Broadcom, cutting an estimated $13.3M.
  • Capital International fully exited Synopsys in Q1 2026, selling an estimated $23.1M.
  • Capital International's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Capital International opened 11 new positions and closed 10 in Q1 2026.
  • Capital International's portfolio value fell 4.9% quarter-over-quarter to $2.7B.

Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.